The development outcome of 16 infants who had rhesus disease was assessed at 18 months. Eight had received intravascular intrauterine transfusion and eight postnatal exchange transfusions. There was no difference in developmental outcome and neither group was different from the population as a whole.
approximately one in 6000 pregnancies.'
Although the incidence of rhesus haemolytic disease has fallen since the introduction of anti-D prophylaxis new cases still occur.
The current approach to the management of severe rhesus disease includes intravascular transfusion.2 This technique allows treatment at a much earlier gestational age than was previously possible thus reducing death from severe anaemia in utero. At by neonatal survival but also by satisfactory development outcome.
Patients, methods, and results
The study group comprised 16 infants who were delivered between July 1986 and June 1988. Eight infants who suffered from rhesus disease and required intrauterine intravascular transfusion were compared with eight selected contemporary control infants. The control infants suffered from rhesus disease requiring close antenatal monitoring but no intrauterine transfusion. Control infants of similar gestational age were selected and all required postnatal exchange transfusion. For one family in very poor social circumstances a similar family for the control group was found (case 7). All 16 children were assessed between 18 and 24 months of age by the consultant in developmental paediatrics (RED) and principal psychologist (CDP) . At the time of assessment neither the paediatrician nor the psychologist were aware of the perinatal history.
The children were given the Cattell infant intelligence test and a neurological and general examination. Weight, length, and occipitofrontal circumference were recorded and walking skills were assessed. Assessment of fine motor skills included cube building and placing of pegs into holes. Behaviour and activity were observed during the consultation and parents were questioned about behaviour and activity at home. Results are shown in tables 1 and 2.
The mean developmental quotient of the treatment group corrected for gestational age was 97-6 (95% confidence interval 87-2 to 108-1) that of the control group was 101-1 (91 -2 to 1 1 1 1 
